- Home
- GFF vs VKTX Comparison
GFF vs VKTX Comparison
Compare GFF & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GFF | VKTX |
|---|---|---|
| Founded | 1959 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.4B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GFF | VKTX |
|---|---|---|
| Price | $84.73 | $33.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $101.50 | $88.00 |
| AVG Volume (30 Days) | 365.8K | ★ 2.9M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.03% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | ★ $2,519,926,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $60.32 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $63.92 | $18.92 |
| 52 Week High | $97.58 | $43.15 |
Technical Indicators
Market Signals| Indicator | GFF | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 57.54 |
| Support Level | $73.42 | $30.73 |
| Resistance Level | $86.11 | $35.66 |
| Average True Range (ATR) | 2.74 | 1.81 |
| MACD | -1.09 | 0.56 |
| Stochastic Oscillator | 9.80 | 75.48 |
Price Performance
Historical ComparisonAbout GFF Griffon Corporation
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.